2RQ-17161-37734 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-12
Dose 1 — Pfizer-BioNTech
2021-03-05
Dose 2 — Pfizer-BioNTech
2021-03-07
Registered in v-safe
2021-03-07
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-03-08
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-10
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-11
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-12
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-03-19
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-03-26
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-04-02
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-04-09
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-04-16
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-06-06
Survey response — 3 months, dose 2
MedDRA: Cough, Headache, Nasopharyngitis — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Cold, headache, cough

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-06
Report sent to call center — 3 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-09
Call 1 — Left Voicemail
2021-09-03
Survey response — 6 months, dose 2
MedDRA: Rhinorrhoea — Feeling: Good

Free text: Runny nose

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-10-14
Dose 3 — Pfizer-BioNTech
Co-administered: Flu
2022-03-07
Survey response — 12 months, dose 2
MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school

Free text: Got a mild case of Covid on 1/11.

MedDRA releases: 2024-11 · check-in free text available
2022-10-14
Health check-in — 12 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-12	Pfizer-BioNTech
2	2021-03-05	Pfizer-BioNTech
3	2021-10-14	Pfizer-BioNTech	Flu

Call center

Reported	Outcome	VAERS-related outcome
2021-06-06	Unsuccessful

Free text

Release 8 — 3 months, dose 2

2021-06-06

Symptoms: Cold, headache, cough

Release 9 — 6 months, dose 2

2021-09-03

Symptoms: Runny nose

Release 11 — 12 months, dose 2

2022-03-07

Symptoms: Got a mild case of Covid on 1/11.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	✓	✓	✓
SD	COVID-19	·	·	✓
SD	Headache	✓	✓	✓
SD	Nasopharyngitis	✓	✓	✓
SD	Rhinorrhoea	✓	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release